E2 Dispensing, for the first time moves the packaging and labeling of investigational drug from a product-centric model to a patient-centric model. In this new model, drug supplies are dispensed to patients by a pharmacist from a central-fill pharmacy, according to the requirements and regulations of the practice of pharmacy rather than dispensed by trained individuals according to the requirements of Good Manufacturing Practices.
E2 Dispensing eliminates unnecessary and redundant steps, delivering a simple, more efficient clinical supply chain. Clinical supplies are labeled and dispensed with a familiar, patient-friendly pharmacy prescription label, improving the quality of compliance and adherence.
E2 Dispensing not only reduces packaging, labeling, distribution, and storage costs, but also leads to a lower burden on Project Managers for planning, forecasting, and implementation as a result of the simplified supply process.
Clinical research is a complicated process, but E2 Dispensing makes it simple.
Check out our E2 Dispensing FAQ to learn how simple switching to E2 Trials can be.
Do you know how state pharmacy regulations apply to investigational drugs and why clinical trials need a central-fill pharmacy?
Subscribe to our email list for access to our next white paper, coming November 20, 2020.
E2 Dispensing eliminates costs associated with unnecessary planning, packaging and labeling of clinical supplies.
Our most current pricing shows up to a 50% cost savings. Request a quote and see for yourself.
E2 Counseling starts with the Clinical Trials Research Pharmacist™ (CTRP®), an RxE2-certified pharmacist who is trained specifically in clinical research. RxE2 incorporates the services of the CTRP to address the study quality issues of adherence, compliance and retention.
CTRPs are able to dispense medication directly to patients and provide patient counseling, either face-to-face or via telepharmacy. When talking with patients, CTRPs use open-ended questions to address patient concerns and gauge patient understanding of and compliance with the study protocol. In previous studies, CTRPs have helped correct patient behaviors regarding a multitude of critical compliance issues, including proper dosage, storage, usage of prohibited concomitant medications, and many others. Importantly, CTRPs are also directly available to patients by phone 24/7, ensuring that patients always have access, day or night, to expert assistance for any of their trial questions, no matter how small.
Today’s pharmacies are untapped resources. Pharmacists build lifetime relationships with their patients on a foundation of trust and one-on-one patient care. RxE2 understands the importance of these relationships and the vital role of the pharmacist in dispensing, compliance, adherence, and retention. The practice of pharmacy is the cornerstone of RxE2’s E2 Dispensing services.
Recruiting patients into clinical trials requires the trust of the patient and personalized, one-on-one interactions between the recruiter and the patient. These requirements may explain why technology has, as yet, been unable to overcome this major hurdle to shortening clinical trial timelines.
The E2 Recruitment model uses trained pharmacists, with their already existing, long-term, patient relationships, to steer potential candidates into clinical trials. After all, who better to recruit patients than the pharmacist, the most trusted medication expert?
RxE2’s unique E2 Recruitment services do more than use technology and data to enroll patients: they add a human touch from trusted medication experts. By using local, independent pharmacies in all corners of the US and the world, RxE2 not only establishes a strong foundation upon which clinical researchers can conduct decentralized trials, but also allows the 85% of the population who have never participated in a clinical trial the chance to get involved.